About this item:

91 Views | 29 Downloads

Author Notes:

Ali A. Asadi-Pooya, Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Fax: +98 7136121052.

Ali A. Asadi-Pooya: Honoraria from Cobel Daruo, Tekaje, Sanofi, Actoverco, and RaymandRad; Royalty: Oxford University Press (Book publication); Grant from the National Institute for Medical Research Development. Eugen Trinka has received personal fees from Arvelle/Angelini, Argenix, UCB, Eisai, Bial, Böhringer Ingelheim, Medtronic, Marinus, MedScape, Everpharma, Epilog, GSK, Biogen, Takeda, Liva-Nova, Newbridge, Novartis, Sanofi, Sandoz, Sunovion, GW Pharmaceuticals, Marinus; grants from Austrian Science Fund (FWF), Österreichische Nationalbank, European Union, GSK, Biogen, Eisai, Novartis, Red Bull, Bayer, and UCB; other from Neuroconsult Ges.m.b.H., outside this work. Abdulaziz Ashkanani: Honoraria as a consultant/advisor & speaker for Novartis, Eli Lilly, NewBridge, and Hikma Co. Others: no conflict of interest.

We thank Shiraz University of Medical Sciences.

Ali A. Asadi-Pooya, M.D.: study design, data collection, statistical analyses, and manuscript preparation. Others: data collection and manuscript preparation.

Subjects:

Research Funding:

This work was supported by Shiraz University of Medical Sciences. The funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Behavioral Sciences
  • Clinical Neurology
  • Psychiatry
  • Neurosciences & Neurology
  • COVID
  • Coronavirus
  • Dissociative
  • PNES
  • Seizure
  • PSYCHOGENIC NONEPILEPTIC SEIZURES
  • RISK-FACTORS
  • SEMIOLOGY
  • ETIOLOGY

An international study of the effects of the COVID-19 pandemic on characteristics of functional seizures

Show all authors Show less authors

Tools:

Journal Title:

EPILEPSY & BEHAVIOR

Volume:

Volume 127

Publisher:

, Pages 108530-108530

Type of Work:

Article | Final Publisher PDF

Abstract:

Objective: We investigated whether the COVID-19 pandemic has affected the clinical characteristics of patients with functional seizure (FS) (at the time of diagnosis) in a large multicenter international study. Methods: This was a retrospective study. We investigated all patients with FS, who were admitted at the epilepsy monitoring units at six centers in the world: 1. Shiraz, Iran; 2. Salzburg, Austria; 3. Nancy, France; 4. Atlanta, USA; 5. Kuwait City, Kuwait; and 6. Cairo, Egypt. Patients were studied during two time periods: admitted in 2018–2019 (pre-COVID era) and 2020–2021 (COVID era). Results: Three hundred and twenty-six patients were studied. Two hundred and twenty-four (68.7%) patients were diagnosed before and 102 (31.3%) persons during the COVID-19 pandemic. Only, a history of family dysfunction was significantly associated with the COVID-19 pandemic era (Odds Ratio: 1.925, 95% Confidence Interval: 1.099–3.371; p = 0.022). A low level of education might also be associated with FS during the COVID-19 pandemic, at least in some cultures (e.g., the Middle-East). Conclusion: The COVID-19 pandemic has not affected the clinical characteristics of patients with FS (at the time of diagnosis). However, a history of family dysfunction was significantly more frequently associated with FS during the COVID-19 pandemic. Multiagency integration of law enforcement responses, social services, and social awareness is recommended to address family dysfunction and domestic violence and support the victims during this pandemic.

Copyright information:

© 2021 Elsevier Inc. All rights reserved.

Export to EndNote